Drugs / Nefiracetam
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00001933 | Jul 1999 → Jan 2002 | Alzheimer disease | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nefiracetam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001933 ↗ |
| Known as | NSC-759830 | ChEMBL registry synonym — accepted as the source's own label CHEMBL260829 ↗ |
| Action | Activate | “nefiracetam enhances the activity of nicotinic acetylcholine receptors” NCT00001933 ↗ |
| Modality | Small molecule | — CHEMBL260829 ↗ |